QA: Eterna Therapeutics Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000748592_2023_Eterna_Therapeutics_Inc.pdf

Logs

Graph

Absolute values for 0000748592, Eterna Therapeutics Inc.

  xvar xval
0 AssetsCurrent 13,681,000
1 IntangibleAssetsNetIncludingGoodwill 2,044,000
2 PropertyPlantAndEquipmentNet 236,000
3 remainder_Assets 6,318,000
4 LiabilitiesCurrent 7,654,000
5 LiabilitiesNoncurrent 981,000
6 remainder_Liabilities 1,537,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 16,835,000
9 ResearchAndDevelopmentExpense 10,392,000
10 remainder_Expenses 6,035,000
11 remainder_Revenues 0
12 remainder_NetIncome 8,683,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 22,279,000
1 Liabilities 10,172,000
2 Expenses 33,262,000
3 Revenues 0
4 StockholdersEquity 12,107,000
5 NetIncome -24,579,000
6 ComprehensiveNetIncome -24,579,000
7 BaseVar 37,198,000
8 EconomicCapitalRatio -0.231

Edgar->Model Mapping

Feature Distribution

Change over Time